Olivier Danos Regenxbio Inc. (RGNX) insider trading activity

Olivier Danos is Chief Scientific Officer of REGENXBIO Inc.. Currently has a direct ownership of 226,348 shares of RGNX, which is worth approximately $1.77 Million. The most recent transaction as insider was on Feb 01, 2025, when has been sold 5,452 shares (Common Stock) at a price of $8.07 per share, resulting in proceeds of $43,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 226K

31.25% 3M change

162.0% 12M change

Total Value Held $1.77 Million

Olivier Danos Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 01 2025	SELL Payment of exercise price or tax liability	$43,997 $8.07 p/Share	5,452 Reduced 2.35%	226,348 Common Stock
Jan 02 2025	SELL Payment of exercise price or tax liability	$97,629 $7.73 p/Share	12,630 Reduced 6.82%	172,453 Common Stock
Jan 02 2025	BUY Grant, award, or other acquisition	-	59,347 Added 20.38%	231,800 Common Stock
Aug 01 2024	BUY Grant, award, or other acquisition	-	58,867 Added 24.13%	185,083 Common Stock
Jun 28 2024	BUY Grant, award, or other acquisition	$13,561 $9.95 p/Share	1,363 Added 1.07%	126,216 Common Stock
Jan 02 2024	SELL Payment of exercise price or tax liability	$150,959 $17.95 p/Share	8,410 Reduced 8.87%	86,391 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	38,462 Added 23.55%	124,853 Common Stock
Jun 30 2023	BUY Grant, award, or other acquisition	$19,079 $16.99 p/Share	1,123 Added 1.17%	94,801 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$46,675 $22.68 p/Share	2,058 Reduced 7.08%	27,020 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	65,930 Added 41.5%	92,950 Common Stock
Jun 30 2022	BUY Grant, award, or other acquisition	$15,288 $21.0 p/Share	728 Added 0.77%	93,678 Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	10,700 Added 26.9%	29,078 Common Stock
Jan 01 2022	SELL Payment of exercise price or tax liability	$39,927 $32.7 p/Share	1,221 Reduced 6.23%	18,378 Common Stock
Dec 31 2021	BUY Grant, award, or other acquisition	$28 $27.8 p/Share	1 Added 0.01%	19,599 Common Stock
Jun 30 2021	BUY Grant, award, or other acquisition	$18,326 $33.02 p/Share	555 Added 2.75%	19,598 Common Stock
Jan 04 2021	BUY Grant, award, or other acquisition	-	11,600 Added 37.86%	19,043 Common Stock
Jun 30 2020	BUY Grant, award, or other acquisition	$20,070 $31.31 p/Share	641 Added 7.93%	7,443 Common Stock
Dec 31 2019	BUY Grant, award, or other acquisition	$10,516 $34.82 p/Share	302 Added 4.25%	6,802 Common Stock

Olivier Danos

Chief Scientific Officer

Rockville, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGNX shares.

Notify only if

Value

Insider Trading

Get notified when an Regenxbio Inc. insider buys or sells RGNX shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENXBIO Inc.

Track Activities on RGNX

Account